Mutation K42R in ribosomal protein S12 does not affect susceptibility of mycobacterium smegmatis 16s rRNA a-site mutants to 2-deoxystreptamines

3Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

Abstract

Recent studies have suggested that ribosomal protein S12 modulates 16S rRNA function and susceptibility to 2- deoxystreptamine aminoglycosides. To study whether the non-restrictive K42R mutation in RpsL affects 2-deoxystreptamine susceptibility in Mycobacterium smegmatis, we studied the drug susceptibility pattern of various mutants with genetic alterations in the 16S rRNA decoding A-site in the context of wild-type and mutant protein S12. RpsL K42R substitution was found not to affect the drug resistance pattern associated with mutational alterations in 16S rRNA H44. © 2010 Kalapala et al.

Cite

CITATION STYLE

APA

Kalapala, S. K., Hobbie, S. N., Böttger, E. C., & Shcherbakov, D. (2010). Mutation K42R in ribosomal protein S12 does not affect susceptibility of mycobacterium smegmatis 16s rRNA a-site mutants to 2-deoxystreptamines. PLoS ONE, 5(8). https://doi.org/10.1371/journal.pone.0011960

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free